COMBIVAR. Trial of two parallel groups to evaluate the efficacy of smoking cessation with combined versus monotherapy

Registry ID
EUCTR2011-004692-36
Source registry
EUCTR
Status
Ongoing
Phase
PHASE3
Sponsor
HOSPITAL UNIVERSITARI DE BELLVITGE
Start date
2011-11-30
Last update
2026-08-16

Conditions

Summary

To determine the efficacy of combined therapy (VRN+nicotine patches) versus monotherapy (VRN+placebo patches) in smoking cessation assessed as continuous abstinence rate (CAR) from week 2 to week 12

Locations

View on source registry